Implementation of the Pharmacopoeia of China 2020

The 2020 edition of the Pharmacopoeia of China will be officially implemented on 30th December, 2020. the National Medical Product Administration issued the implementation notice of the Pharmacopoeia of China 2020 on July 6, explaining the adoption of standards, the management of drugs not included, and the transitional period of drug registration. Pharmacopoeia of China is the legal technical standards of drug development, production (import), marketing, use and supervision and management. Drugs not included shall implement the old edition of Pharmacopoeia and the standards issued by the Bureau (Ministry), and meet also the relevant general technical requirements of this editionRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field